Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
Company Profile
| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 40.89 mm | 40.89 mm | ||||
| Cash burn (monthly) | 12.11 mm | 4.32 mm | ||||
| Cash used (since last report) | 61.34 mm | 21.90 mm | ||||
| Cash remaining | -20.45 mm | 18.99 mm | ||||
| Runway (months of cash) | -1.7 | 4.4 | ||||
| 13F holders | Current |
|---|---|
| Total holders | 51 |
| Opened positions | 9 |
| Closed positions | 7 |
| Increased positions | 16 |
| Reduced positions | 14 |
| 13F shares | Current |
|---|---|
| Total value | 255.79 bn |
| Total shares | 13.60 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| JNJ Johnson & Johnson | 1.98 mm | $37.88 bn |
| Suvretta Capital Management | 1.72 mm | $32.92 bn |
| Perceptive Advisors | 1.52 mm | $29.03 bn |
| BEN Franklin Resources | 1.45 mm | $23.63 bn |
| Versant Venture Management | 918.16 k | $17.57 bn |
| Sectoral Asset Management | 800.89 k | $15.33 bn |
| FMR | 696.93 k | $13.34 bn |
| Hillhouse Capital Advisors | 669.34 k | $12.81 bn |
| Samsara BioCapital | 588.82 k | $11.27 bn |
| Vanguard | 461.33 k | $8.83 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 25 | Carmine N. Stengone | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 9.79 | 300,000 | 2.94 mm | 300,000 |
| 31 Jan 25 | Stephen L. Huhn | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 9.79 | 110,000 | 1.08 mm | 110,000 |
| 31 Jan 25 | Daniel S. Lorrain | Stock Option Class A Common Stock | Grant | Acquire A | Yes | No | 9.79 | 3,700 | 36.22 k | 3,700 |
| 31 Jan 25 | Daniel S. Lorrain | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 9.79 | 110,000 | 1.08 mm | 110,000 |
| 31 Jan 25 | Peter T Slover | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 9.79 | 110,000 | 1.08 mm | 110,000 |
| 31 Jan 25 | John Stephen Healy | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 9.79 | 63,589 | 622.54 k | 63,589 |